Bone Biologics Corp
BBLG- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.
Other share classesBBLGW
Q3 2022 vs. Q2 2022
How the institutions holding Bone Biologics Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 47.3K | 41.4K | −5.94K (−12.6%) |
| Value | $67.0K | $43.0K | −$24.0K (−35.8%) |
New holders (1)
Institutions that held Bone Biologics Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wells Fargo & Company | 21 | $0 | 0.00% |
Sold out (1)
Institutions that held Bone Biologics Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| UBS Group AG | 7,673 | $11.0K |